Reid Hoffman leaves Microsoft’s board to go ‘founder mode’ with AI drug startup Manus

The Next Web
Read full post
Reid Hoffman has resigned from Microsoft's board to focus on leading Manus, an AI-driven drug discovery startup. This move marks his shift towards entrepreneurship in the AI healthcare sector.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI
Healthcare3 min read

Google’s map of every possible DNA typo could speed up rare disease research

Covered by 3 sources